South Korea and Australia offer solutions for radiopharma trial bottlenecks
In the context of the increasing prevalence of chronic diseases, the global radiopharmaceutical market is gaining momentum and is projected…
In the context of the increasing prevalence of chronic diseases, the global radiopharmaceutical market is gaining momentum and is projected…
The UAE is quickly advancing its precision medicine and genomics capabilities, establishing itself as a major emerging global clinical trial…
The Asia-Pacific (APAC) clinical trial landscape is undergoing a shift, with clinical trial activity rising two to three times faster…
At the upcoming Outsourcing in Clinical Trials (OCT) and Clinical Trial Supply (CTS) Korea 2025 meetings, which will take place…
The biotech sector has faced a challenging first half of 2025, underperforming relative to the broader tech industry and the…
“In the future, 30% of trial data will come from the clinic, while 70% will be sourced by decentralised clinical…
“Failure to recruit patients for trials leads to delays in drug development, which are bad both for sponsors and patients,”…
Recent changes at the US Food and Drug Administration (FDA) have changed the circumstances for rare disease drug development, but…
“The biggest shifts in rare disease clinical research are occurring in platform and basket trials, which from the perspective of…
In September 2025, leading professionals across the biotech and pharmaceutical industries will gather and discuss solutions to exchange insights about…